Ticker > Company >

FDC share price

FDC Ltd.

NSE: FDC BSE: 531599 SECTOR: Pharmaceuticals & Drugs  94k   335   52

478.90
-2.20 (-0.46%)
NSE: Today, 09:34 AM

Price Summary

Today's High

₹ 483.9

Today's Low

₹ 478.5

52 Week High

₹ 658.85

52 Week Low

₹ 402

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

7796.97 Cr.

Enterprise Value

7775.36 Cr.

No. of Shares

16.28 Cr.

P/E

24.71

P/B

3.41

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  140.44

CASH

21.65 Cr.

DEBT

0.03 Cr.

Promoter Holding

69.66 %

EPS (TTM)

₹  19.38

Sales Growth

7.83%

ROE

15.06 %

ROCE

19.71%

Profit Growth

52.84 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of FDC Ltd.

Electral Enerzal Vitcofol Pyrimon Zocon Zoxan Zathrin Zipod Zefu Cotaryl and Mycoderm

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.83%
3 Year13.07%
5 Year12.24%

Profit Growth

1 Year52.84%
3 Year1.41%
5 Year12.36%

ROE%

1 Year15.06%
3 Year12.42%
5 Year14.38%

ROCE %

1 Year19.71%
3 Year16.36%
5 Year18.91%

Debt/Equity

0

Price to Cash Flow

35.31

Interest Cover Ratio

100.4863

CFO/PAT (5 Yr. Avg.)

0.785475588818322

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 69.66 0.00
Jun 2024 69.66 0.00
Mar 2024 69.66 0.00
Dec 2023 69.66 0.00
Sep 2023 69.66 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.0759 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 100.4863.
  • Company’s PEG ratio is 0.443218372097309.
  • The company has an efficient Cash Conversion Cycle of -15.4044 days.
  • Company has a healthy liquidity position with current ratio of 2.2134.
  • The company has a high promoter holding of 69.66%.

 Limitations

  • The company has shown a poor profit growth of 1.41440480613739% for the Past 3 years.
  • The company has shown a poor revenue growth of 13.0726953498798% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 479.7 452.22 454.23 624.14 505.1
Total Expenditure 400.99 370.31 396.39 482.45 432.7
Operating Profit 78.71 81.9 57.84 141.69 72.4
Other Income 27.39 25.33 20.72 28.15 34.68
Interest 1.05 0.97 0.94 1.29 1.07
Depreciation 9.81 9.93 10.4 11 13.76
Exceptional Items 0 0 0 0 0
Profit Before Tax 95.23 96.33 67.22 157.56 92.25
Tax 23.19 17.96 19.02 42.57 18.28
Profit After Tax 72.04 78.38 48.2 114.99 73.97
Adjusted EPS (Rs) 4.42 4.81 2.96 7.06 4.54

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1331.09 1325.45 1518.97 1777.03 1916.19
Total Expenditure 1047.51 1001.12 1272.12 1523.84 1577.73
Operating Profit 283.58 324.33 246.85 253.19 338.46
Other Income 82.66 97.15 78.73 55.29 103.22
Interest 3.41 3.4 3.05 4.04 4
Depreciation 37.36 37.62 37.08 38.76 39.73
Exceptional Items 0 0 0 0 0
Profit Before Tax 325.46 380.45 285.45 265.69 397.95
Tax 78.68 85.96 65.82 64.72 90.78
Net Profit 246.78 294.49 219.64 200.97 307.16
Adjusted EPS (Rs.) 14.43 17.45 13.01 12.11 18.87

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 17.1 16.88 16.88 16.59 16.28
Total Reserves 1524.72 1705.28 1931.8 1964.15 2080.92
Borrowings 0.34 0.21 0.11 0.03 0
Other N/C liabilities 314.27 299.36 384.32 462.62 597.62
Current liabilities 562.37 620.07 688.6 728.67 612.23
Total Liabilities 2418.8 2641.8 3021.71 3172.07 3307.04
Assets
Net Block 669.77 685.02 700.97 694.93 676.39
Capital WIP 23.85 19.21 104.24 197.73 260.88
Intangible WIP 0 0 0.11 0.11 0
Investments 162.53 265.58 384.95 348.71 399.7
Loans & Advances 320.85 328.73 424.04 487.39 609.5
Other N/C Assets 0.73 5.03 0.84 3.3 5.45
Current Assets 1241.06 1338.24 1406.56 1439.89 1355.13
Total Assets 2418.8 2641.8 3021.71 3172.07 3307.04
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 325.46 380.45 285.45 265.69 397.95
Adjustment 8.36 -40.75 -23.59 1 -52.32
Changes in Assets & Liabilities -11 -36.05 -21.17 -25.11 -21.91
Tax Paid -83.78 -93.81 -78.31 -76.86 -102.9
Operating Cash Flow 239.04 209.84 162.38 164.72 220.81
Investing Cash Flow -84.89 -84.15 -147.27 3.73 -17.75
Financing Cash Flow -142 -126.49 -9.7 -179.83 -202.03
Net Cash Flow 12.16 -0.8 5.41 -11.38 1.02

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 69.66 69.66 69.66 69.66 69.66
aditi c bhanot 0.68 0.68 0.68 0.68 0.68
ameya ashok chandavarkar 6.10 6.10 6.10 6.10 6.10
leo advisors pvt ltd 9.17 9.17 9.17 9.17 9.17
nandan mohan chandavarkar... 3.10 3.10 3.10 3.10 24.92
nomita r chandavarkar 3.23 3.23 22.67 22.67 22.67
virgo advisors pvt ltd 6.12 6.12 6.12 6.12 6.12
nandan mohan chandavarkar... - - 11.01 11.01 -
nandan mohan chandavarkar... - - - 10.81 -
nandan mohan chandavarkar... - - 10.81 - -
meera ramdas chandavarkar... 19.44 19.44 - - -
nandan mohan chandavarkar... 10.81 10.81 - - -
nandan mohan chandavarkar... 11.01 11.01 - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 30.34 30.34 30.34 30.34 30.34
icici prudential smallcap... - - - - 2.51
investor education and pr... - - 0.22 0.22 0.22
llp 0.06 0.05 0.05 0.06 0.08
nippon life india trustee... 2.63 2.64 2.64 2.64 2.61
icici prudential smallcap... 4.24 3.79 3.11 3.17 -
investor education and pr... 0.22 0.22 - - -

Ratings & Research Reports

Company Presentations

Company News

FDC informs about certificate 10 Jan, 5:23 PM FDC informs about compliances-certificate 10 Jan, 5:22 PM FDC informs about issuance of duplicate share certificates 26 Dec, 5:06 PM FDC informs about closure of trading window 26 Dec, 3:28 PM FDC gets final nod for Cefixime 400 mg Tablets 18 Dec, 5:08 PM FDC informs about disclosure 18 Dec, 4:56 PM FDC informs about loss of share certificate 13 Dec, 5:14 PM FDC submits intimation of company's new correspondence address 12 Dec, 1:18 PM FDC recalling 1,55,232 bottles of Timolol Maleate ophthalmic solution in US market 18 Nov, 11:00 AM FDC - Quaterly Results 6 Nov, 4:21 PM FDC - Quaterly Results 6 Nov, 4:21 PM FDC - Quaterly Results 6 Nov, 4:21 PM FDC recalling bottles of Timolol Maleate Ophthalmic Solution 27 Aug, 2:42 PM FDC informs about updates 23 Aug, 5:31 PM USFDA completes audit at FDC’s Baddi manufacturing facility 23 Aug, 4:30 PM FDC informs about disclosure 8 Aug, 3:28 PM FDC - Quaterly Results 7 Aug, 3:03 PM FDC - Quaterly Results 7 Aug, 3:03 PM FDC - Quaterly Results 7 Aug, 3:03 PM FDC informs about board meeting 26 Jul, 5:22 PM FDC informs about certificate 12 Jul, 2:27 PM FDC informs about closure of trading window 25 Jun, 2:42 PM FDC informs about details of loss of certificate 15 Jun, 1:27 PM FDC informs about press release 30 May, 2:59 PM FDC - Quaterly Results 29 May, 5:44 PM FDC - Quaterly Results 29 May, 5:44 PM FDC - Quaterly Results 29 May, 5:44 PM FDC informs about compliance certificate 20 Apr, 12:54 PM FDC informs about disclosure 3 Apr, 2:25 PM FDC - Quaterly Results 7 Feb, 2:44 PM FDC - Quaterly Results 7 Feb, 2:44 PM FDC - Quaterly Results 7 Feb, 2:44 PM FDC informs about certificate 9 Jan, 2:55 PM FDC informs about details of loss of certificate 16 Dec, 2:45 PM FDC submits investor presentation 16 Nov, 12:43 PM FDC - Quaterly Results 8 Nov, 6:27 PM FDC - Quaterly Results 8 Nov, 6:27 PM FDC informs about post offer public announcement 15 Sep, 3:10 PM FDC - Quaterly Results 9 Aug, 7:56 PM FDC - Quaterly Results 9 Aug, 7:56 PM FDC submits board meeting intimation 1 Aug, 1:07 PM FDC informs about details of loss of certificate 1 Jul, 1:00 PM FDC gets EIR from USFDA for Aurangabad manufacturing facility 15 Jun, 3:52 PM FDC gets EIR from USFDA for Roha manufacturing facility 15 Jun, 2:51 PM FDC informs about newspaper advertisement 14 Jun, 11:19 AM FDC - Quaterly Results 25 May, 7:43 PM FDC - Quaterly Results 25 May, 7:43 PM FDC informs about non-applicability of large corporate entity 19 Apr, 4:24 PM FDC informs about compliance certificate 14 Apr, 4:26 PM FDC informs about updates 27 Mar, 4:31 PM

FDC Stock Price Analysis and Quick Research Report. Is FDC an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into FDC and its performance over the period of time. FDC stock price today is Rs 478.5.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. FDC cash from the operating activity was Rs 220.808 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. FDC has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In FDC , the EPS growth was 55.7525 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, FDC has OPM of 17.6630934245979 % which is a good sign for profitability.
     
  • ROE: FDC have a average ROE of 15.0646 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of FDC is Rs 478.5. One can use valuation calculators of ticker to know if FDC share price is undervalued or overvalued.
Last Updated on:
Brief about FDC

FDC Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

FDC Ltd. is a renowned pharmaceutical company in India, known for its exceptional portfolio of healthcare products. This detailed stock analysis aims to provide long-term stock investors with valuable insights into various aspects of the company's financial performance, without including numbers or financial data points.

FDC Ltd. Share Price Assessment

The share price of FDC Ltd. has demonstrated a consistent track record with moderate fluctuations over time. As of the latest available information, the stock is trading at a competitive price. Investors looking for a well-performing pharmaceutical company can utilize our pre-built screening tools to monitor the share price and make informed investment decisions. A stock's share price is determined by a range of factors such as market sentiment, financial performance, and general economic conditions.

FDC Ltd. Balance Sheet Evaluation

FDC Ltd.'s balance sheet reveals a strong financial position with stable growth in assets such as inventory, property, and receivables. The company's liabilities primarily consist of borrowings and payables. The balance sheet evaluation can help investors assess the company's liquidity and financial stability. Our premium feature tools, including DCF Analysis, BVPS Analysis, Earnings Multiple Approach, and DuPont Analysis, provide an in-depth analysis of the company's performance.

FDC Ltd. Annual Report Insights

Investors can gain a deep understanding of FDC Ltd.'s operations, financial performance, and future prospects by reviewing the company's annual reports, which are available for download on our website. These reports provide essential information about the company's management policies, business strategies, and financial targets.

FDC Ltd. Dividend Analysis

FDC Ltd. has a consistent dividend payment record, which can be of interest to long-term stock investors. Our pre-built screening tools allow investors to track the company's dividend history and payout ratios. Dividend analysis aids investors in understanding the company's dividend policy and the potential returns associated with holding FDC Ltd. stock.

FDC Ltd. Quarterly Result Review

The quarterly results of FDC Ltd. offer relevant information regarding the company's revenue, net income, and EPS (earnings per share). Access to the latest quarterly results provides investors with insights into the company's financial performance on a more frequent basis. Utilize our website to download these results and compare them with previous quarters. Our premium feature tools can facilitate a more detailed analysis of FDC Ltd.'s quarterly performance.

FDC Ltd. Stock Price Chart Analysis

The stock price chart for FDC Ltd. displays a steady growth pattern with occasional fluctuations. Investors can use the chart to evaluate the stock's historical performance and assess its potential for long-term growth. Analysis of the stock price chart aids investors in understanding market trends and making informed investment decisions. Our website provides pre-built screening tools to help investors analyze stock price and performance.

FDC Ltd. News and Concall Updates

Stay up to date with the latest news and updates on FDC Ltd. through our website, which provides information on earnings announcements, management changes, and industry developments. Additionally, we offer access to transcripts of company concalls, enabling investors to gain further insights into FDC Ltd.'s operations and strategies.

FDC Ltd. Investor Presentations Examination

Investor presentations offered by FDC Ltd. showcase the company's business models, growth plans, and financial targets. By reviewing these presentations, investors can gain a better understanding of the company's vision and evaluate its potential for long-term success. Our website provides access to these investors presentations for thorough analysis.

FDC Ltd. Promoters and Shareholders Insight

FDC Ltd. boasts a dedicated group of promoters with extensive experience in the pharmaceutical industry. The company's shareholders include a blend of retail investors, institutional investors, and mutual funds. Learn more about FDC Ltd.'s promoter group and major shareholders through our website.

FDC Limited ROCE

The Return on Capital Employed (ROCE) is an important ratio that determines the profitability and efficiency of a company's capital investments. FDC Limited's ROCE can be found in the financials table or ratio section on this page. ROCE indicates how well the company uses its capital to generate profits and is expressed as a percentage. A higher ROCE suggests better capital allocation and profitability for FDC Limited.

FDC Limited EBITDA

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. This financial metric provides a measure of a company's operating performance without the impact of financial and accounting decisions. FDC Limited's EBITDA can be accessed in the financials table or ratio section. EBITDA is useful for comparing companies' profitability and is often used as an indicator of cash flow generation.

FDC Limited DPS

Dividends Per Share (DPS) is a financial ratio that represents the portion of a company's earnings distributed to its shareholders in the form of dividends. FDC Limited's DPS information is available in the financials table or ratio section. DPS is useful for investors looking for income from their investments, as it indicates the dividend payout per share and highlights the company's dividend policy and financial stability.

FDC Limited EPS

Earnings Per Share (EPS) is a common financial ratio that represents the portion of a company's profit allocated to each outstanding share of common stock. FDC Limited's EPS can be found in the financials table or ratio section on this page. EPS is a crucial metric for investors as it provides an indicator of a company's profitability and allows for comparison across different companies in the industry.

Please note that the specific values and trends for all these ratios can be found in the financials table or ratio section provided on this page.

Read More
X